How to buy COMPASS Pathways stock | $36.65

COMPASS Pathways plc (CMPS) is a leading other business based in the US. It opened the day at $35.77 after a previous close of $33.91. During the day the price has varied from a low of $35.10 to a high of $37.02. The latest price was $36.65 (25 minute delay). COMPASS Pathways is listed on the NASDAQ and employs 61 staff. All prices are listed in US Dollars.

COMPASS Pathways stock price (NASDAQ: CMPS)

Use our graph to track the performance of CMPS stocks over time.

COMPASS Pathways shares at a glance

• Live prices
• Key figures

Information last updated 2021-07-09.

Open	$35.77
High	$37.02
Low	$35.10
Close	$36.65
Previous close	$33.91
Change	$2.74
Change %	8.0802%
Volume	569,575

Information last updated 2021-07-28.

52-week range	$22.51 - $61.69
50-day moving average	$36.53
200-day moving average	$39.07
Wall St. target price	$72.88
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy COMPASS Pathways shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy COMPASS Pathways stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of COMPASS Pathways plc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

COMPASS Pathways price performance over time

Historical closes compared with the close of $36.65 from 2021-05-28

1 week (2021-07-22)	N/A
1 month (2021-07-02)	-1.66%
3 months (2021-04-30)	0.99%
6 months (2021-01-29)	N/A

1 year (2020-07-29)	N/A
2 years (2019-07-29)	N/A
3 years (2018-07-29)	N/A
5 years (2016-07-29)	N/A

COMPASS Pathways financials

Gross profit TTM	$0
Return on assets TTM	-29.06%
Return on equity TTM	-67.93%
Profit margin	0%
Book value	$5.13
Market capitalisation	$1.5 billion

TTM: trailing 12 months

Shorting COMPASS Pathways shares

There are currently 467,120 COMPASS Pathways shares held short by investors – that's known as COMPASS Pathways's "short interest". This figure is 64.1% down from 1.3 million last month.

There are a few different ways that this level of interest in shorting COMPASS Pathways shares can be evaluated.

COMPASS Pathways's "short interest ratio" (SIR)

COMPASS Pathways's "short interest ratio" (SIR) is the quantity of COMPASS Pathways shares currently shorted divided by the average quantity of COMPASS Pathways shares traded daily (recently around 491705.26315789). COMPASS Pathways's SIR currently stands at 0.95. In other words for every 100,000 COMPASS Pathways shares traded daily on the market, roughly 950 shares are currently held short.

To gain some more context, you can compare COMPASS Pathways's short interest ratio against those of similar companies.

• Catalyst Biosciences (CBIO.US): 1.98
• Moderna (MRNA.US): 1.71
• Cassava Sciences (SAVA.US): 1.5

However COMPASS Pathways's short interest can also be evaluated against the total number of COMPASS Pathways shares, or, against the total number of tradable COMPASS Pathways shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case COMPASS Pathways's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 COMPASS Pathways shares in existence, roughly 10 shares are currently held short) or 0.021% of the tradable shares (for every 100,000 tradable COMPASS Pathways shares, roughly 21 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against COMPASS Pathways.

Find out more about how you can short COMPASS Pathways stock.

COMPASS Pathways share dividends

We're not expecting COMPASS Pathways to pay a dividend over the next 12 months.

COMPASS Pathways overview

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. .

Frequently asked questions

What percentage of COMPASS Pathways is owned by insiders or institutions?
Currently 4.51% of COMPASS Pathways shares are held by insiders and 12.634% by institutions. How many people work for COMPASS Pathways?
Latest data suggests 61 work at COMPASS Pathways. When does the fiscal year end for COMPASS Pathways?
COMPASS Pathways's fiscal year ends in December. Where is COMPASS Pathways based?
COMPASS Pathways's address is: 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT What is COMPASS Pathways's ISIN number?
COMPASS Pathways's international securities identification number is: US20451W1018